Taysha Gene Therapies

discovering, developing and commercializing gene therapies for the CNS

Based in TX

🤖

AI Overview

With $110K in lobbying spend across 13 quarterly filings, Taysha Gene Therapies is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2020 to 2023.

$110K
Total Spend
4
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$10K
2021$40K
2022$40K
2023$20K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Taysha Gene Therapies disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

Medicare reimbursement, CURES 2.0,

Medicare reimbursement, CURES 2.0

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.